Correction to: Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-ß pathway.

Kang, Eunji; Kim, Kanggeon; Jeon, Sook Young; Jung, Ji Gwang; Kim, Hong-Kyu; Lee, Han-Byoel; Han, Wonshik

Kang, Eunji; Kim, Kanggeon; Jeon, Sook Young; Jung, Ji Gwang; Kim, Hong-Kyu; Lee, Han-Byoel; Han, Wonshik.

Afiliación

Kang E; Cancer Research Institute, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea.
Kim K; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Jeon SY; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea.
Jung JG; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea.
Kim HK; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea.
Lee HB; Cancer Research Institute, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea.
Han W; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea.

Cancer Gene Ther ; 29(8-9): 1302, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35859166

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Cancer Gene Ther Asunto de la revista: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google